Tyler and Lauren’s Journeys with Bardet Biedl Syndrome
FDNA highlights eye disorders in June for the Year of Discovery. We are uniting healthcare, advocacy and technology for rare disease Read more
Emma and Naomi’s Journeys with Bardet Biedl Syndrome
Special thanks to Kathy Eby for sharing her daughters’ journeys and for co-authoring this post. Read her article on “Why Read more
Facial Analysis Discoveries for Sanfilippo Syndrome B (MPS IIIB)
In May, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect and Read more
Miriam’s Journey with MPS IIIB
FDNA highlighted metabolic disorders and LSDs during May for the Year of Discovery. We are uniting healthcare, advocacy and technology Read more
Age-specific Facial Analysis Discoveries for Overgrowth Syndromes in the Year of Discovery
In April 2017, FDNA analyzed patient data from syndromes categorized as Overgrowth Syndromes as part of the Year of Discovery, Read more
Spotlight on Metabolic Disorders and LSDs for the Year of Discovery
Special thanks to ThinkGenetic for contributing this post. This month, the Year of Discovery spotlights metabolic disorders and LSDs. Uploading cases Read more
Romana’s Journey with Sotos Syndrome
This month in the Year of Discovery, FDNA spotlights overgrowth syndromes. Every case uploaded in April will be matched with Read more
New Facial Analysis Discoveries for RASopathy Syndromes in the Year of Discovery
In March, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect Read more
FDNA Spotlights Overgrowth Syndromes During the Year of Discovery
FDNA’s Year of Discovery Initiative is taking on a different genetic syndrome group each month as part of its mission Read more
From Genomics to Groceries, the Future Belongs to Those That Use A.I.
published as part of Access A.I.’s publication: “AI and Business: a Practical Guide.“ Our world is filled with data. Data Read more
Drew’s Journey with Noonan Syndrome
This month in the Year of Discovery, FDNA spotlights syndromes categorized as RASopathies. Every case uploaded in March will be Read more
How data warehouses can speed identification of rare diseases
Dekel Gelbman, CEO of FDNA, was featured in Health Data Management discussing the value for hospitals of using clinical data Read more
FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery
FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to Read more
Pinpointing Rare Diseases with Facial Analysis and Phenotyping Technology
Dekel Gelbman, CEO of FDNA, was featured in Medical Device and Diagnostics Industry, discussing the value of facial analysis technology Read more
Phenotyping technologies save on costs and improve rare disease workflows
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in Read more
FDNA Launches “Year of Discovery” for Rare Disease Day
FDNA Launches “Year of Discovery” for Rare Disease Day Boston-based health and tech start-up calls on patients and clinicians to share Read more